Maintenance of serum potassium with sodium zirconium cyclosilicate ( ZS ‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial-Reference-Cited by-同舟云学术

Maintenance of serum potassium with sodium zirconium cyclosilicate ( ZS ‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial

Published:2015-06-16 Issue:10 Volume:17 Page:1050-1056
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Anker Stefan D.¹,Kosiborod Mikhail²,Zannad Faiez³,Piña Ileana L.⁴,McCullough Peter A.⁵,Filippatos Gerasimos⁶,van der Meer Peter⁷,Ponikowski Piotr⁸,Rasmussen Henrik S.⁹,Lavin Philip T.¹⁰,Singh Bhupinder⁹,Yang Alex⁹,Deedwania Prakash¹¹

Affiliation:

1. Innovative Clinical Trials, Department of Cardiology & Pneumology University Medical Centre Göttingen (UMG) Robert‐Koch‐Strasse 40 D–37075 Göttingen Germany

2. Saint Luke's Mid America Heart Institute and University of Missouri–Kansas City Kansas City MO USA

3. Inserm Université de Lorraine Vandoeuvre‐Les‐Nancy France

4. Albert Einstein COM/Montefiore Medical Center Bronx NY USA

5. Baylor University Medical Center, Baylor Heart and Vascular Institute Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX, and The Heart Hospital Plano TX USA

6. Athens University Hospital Attikon Athens Greece

7. University of Groningen University Medical Centre Groningen the Netherlands

8. Wroclaw Medical University Wrocław Poland

9. ZS Pharma, Inc. Coppell TX USA

10. Boston Biostatistics Research Foundation Framingham MA USA

11. University of California San Francisco CA USA

Funder

ZS Pharma Inc.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine